Journal
New England Journal of Medicine
Publication Date
7-4-2024
Volume
391
Issue
1
First Page
32
Last Page
43
Document Type
Open Access Publication
DOI
10.1056/NEJMoa2314192
Rights and Permissions
Riedl MA, Farkas H, Aygören-Pürsün E, Psarros F, Soteres DF, Staevska M, Cancian M, Hagin D, Honda D, Melamed I, Savic S, Stobiecki M, Busse PJ, Dias de Castro E, Agmon-Levin N, Gower R, Kessel A, Kurowski M, Lleonart R, Grivcheva Panovska V, Wedner HJ, Audhya PK, Hao J, Iverson M, Smith MD, Yea CM, Lumry WR, Zanichelli A, Bernstein JA, Maurer M, Cohn DM; KONFIDENT Investigators. Oral Sebetralstat for On-Demand Treatment of Hereditary Angioedema Attacks. N Engl J Med. 2024 Jul 4;391(1):32-43. doi: 10.1056/NEJMoa2314192. Copyright © 2024 Massachusetts Medical Society. Reprinted with permission.
Recommended Citation
Riedl, Marc A; Wedner, H James; and et al., "Oral sebetralstat for on-demand treatment of hereditary angioedema attacks." New England Journal of Medicine. 391, 1. 32 - 43. (2024).
https://digitalcommons.wustl.edu/oa_4/4582
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
